常州市存仁生物工程有限公司

产品 > Receptor Tyrosine Kinases > EGFR(HER) > PF299804|达克替尼
产品名称 : PF299804|达克替尼
型号 : CR1187
CAS : 1110813-31-4
 放大                   返回
←[上一个产品]              [下一个产品]→


产品详细:
Description of:PF299804
PF299804 is a quinazalone-based irreversible pan-ERBB inhibitor structurally related to CI-1033. PF299804 is a potent inhibitor of EGFR-activating mutations as well as the EGFR T790M resistance mutation both in vitro and in vivo. Additionally, PF299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancers. PF299804 effectively inhibited the in vitro kinase activity of wild-type EGFR with similar efficacy as gefitinib, erlotinib, andCI-1033.

Theoretical analysis:PF299804
M.Wt: 469.94
Formula: C24H25ClFN5O2
Solubility: Unknown
Purity: >99%
Storage: at -20℃ 2 years
CAS No.: 1110813-31-4

Availability and price:PF299804
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :
orders@chemrenblock.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days

备注:
若要询价或订购,请打销售电话咨询:0519-85788828,或加QQ:2500035664咨询,量大从优,我们会尽快回复。

相关产品 :
WZ3146
WZ3146
WZ4002
WZ4002
WZ8040
WZ8040
PD153035
PD153035
Pelitinib(EKB-569)|培利替尼
Pelitinib(EKB-569)|培利替尼
来那替尼|Neratinib(HKI-272)
来那替尼|Neratinib(HKI-272)
Lapatinib
Lapatinib